Latest Earnings Results: Q2 '26
Estimated EPS
$6.21
Reported EPS
$7.45
Surprise
+19.94%
Estimated Rev
$48.84B
Reported Rev
$49.83B
Surprise
+2.01%
$ELV Q2 '26 Earnings Results & Recap Elevance Health raised its full-year 2026 diluted EPS guidance to at least $20.10 and adjusted diluted EPS guidance to at least $27.00, while raising operating cash flow guidance to $6.0 billion.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | $4.73 | -- | -- | N/A |
Q2 '26 | $6.21 | $7.45 | 19.94% | BEAT |
Q1 '26 | $11.03 | $12.58 | 14.02% | BEAT |
Q4 '25 | $3.10 | $3.33 | 7.54% | BEAT |
Q3 '25 | $4.93 | $6.03 | 22.24% | BEAT |



